Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 28, 2009; 15(20): 2456-2462
Published online May 28, 2009. doi: 10.3748/wjg.15.2456
Published online May 28, 2009. doi: 10.3748/wjg.15.2456
HLA antigens investigated | Percentage in IBD + arthropathy affected patients | Percentage in IBD patients without arthropathy | |
AS | HLA-B*27 | 60 | 7 |
TypeIarthritis | HLA-B*27 | 26 | 7 |
HLA-B*35 | 33 | 15 | |
HLA-DRB1*0103 | 35 | 3 | |
Type II arthritis | HLA-B*44 | 62 | 31 |
Genes and loci | Associated with CD | Associated with UC | |
1p31 | IL23R | Yes | Yes |
1q21 | ECM1 | - | Yes |
2q37 | ATG16L1 | Yes | No |
3p21 | Several included MST1-BSN | Yes | Yes |
5p13 | Intergenic, PTGR4 | Yes | No |
5q31 | Several included SLC22A5 | Yes | Yes |
5q33 | IRGM | Yes | No |
5q33 | IL12B | Yes | Yes |
6q21 | HLA-DQ/DR | Yes | Yes |
10q21 | ZNF365 | Yes | Yes |
10q24 | NKX2-3 | Yes | Yes |
16q12 | NOD2 | Yes | No |
17q21 | Several included STAT3 | Yes | Yes |
18p11 | PTPN2 | Yes | Yes |
- Citation: Colombo E, Latiano A, Palmieri O, Bossa F, Andriulli A, Annese V. Enteropathic spondyloarthropathy: A common genetic background with inflammatory bowel disease? World J Gastroenterol 2009; 15(20): 2456-2462
- URL: https://www.wjgnet.com/1007-9327/full/v15/i20/2456.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2456